Latest Financials News

Nufarm Limited posted a 3% revenue increase to $1.81 billion for the half-year ending March 2025, driven by Crop Protection growth, yet profits fell sharply due to omega-3 inventory write-downs and higher costs. The company withheld its interim dividend amid ongoing operational challenges.

Catapult Group International has reported a milestone FY25, surpassing US$100 million in Annualized Contract Value and delivering a record US$8.6 million in free cash flow, underscoring its growing dominance in sports technology.

Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.

Ardea Resources has received a $1.2 million R&D tax incentive rebate from the Australian Government, reinforcing its innovative work at the Kalgoorlie Nickel Project and strengthening its financial position.

Dalrymple Bay Infrastructure Limited has announced a quarterly dividend of 5.875 cents per stapled security, combining a partly franked dividend and a partial loan note repayment, payable in June 2025.

Dalrymple Bay Infrastructure Limited forecasts a 3.6% increase in terminal charges and a 6.5% uplift in distributions for the 2025/26 financial year, confirming steady growth and full terminal capacity.

White Cliff Minerals has delivered compelling assay results from its Rae Copper Project in Nunavut, revealing continuous high-grade copper mineralisation from surface and securing $14.4 million for ongoing 2025 drilling.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

SGH Ltd has reaffirmed its FY25 guidance for high single-digit EBIT growth while targeting a net debt to EBITDA ratio of 2.0x by year-end, underpinned by disciplined capital allocation and operational improvements across its diversified industrial, energy, and media businesses.

KPMG's latest actuarial report reveals a slight increase in asbestos-related disease liabilities for former James Hardie entities, driven by a notable rise in mesothelioma claims and evolving actuarial assumptions.

James Hardie Industries plc reported a slight dip in FY25 sales and profits but met guidance, while announcing a transformative acquisition of The AZEK Company Inc to accelerate growth and synergies.

James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.